Literature DB >> 21941417

Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

Kazuhiro Saito1, Fuminori Moriyasu, Katsutoshi Sugimoto, Ryota Nishio, Toru Saguchi, Toshitaka Nagao, Junichi Taira, Soichi Akata, Koichi Tokuuye.   

Abstract

AIM: To evaluate the relationship between the signal intensity of hepatobiliary phase images on gadoxetic acid-enhanced magnetic resonance imaging (MRI) and histological grade.
METHODS: Fifty-nine patients with 82 hepatocellular lesions were evaluated retrospectively. Hepatobiliary phase images on gadoxetic acid-enhanced MRI were classified into 3 groups: low, iso or high. Angiography-assisted computed tomography (CT) findings were also classified into 3 groups: CT during arterial portography, and CT hepatic arteriography: A: iso, iso or low; B: slightly low, iso or low; and C: low, high. We correlated angiography-assisted CT, hepatobiliary phase findings during gadoxetic acid-enhanced MRI and histological grades. Furthermore, correlations between MRI findings and histological grade for each hemodynamic pattern were performed. Correlations among radiological and pathological findings were statistically evaluated using the chi-square test and Fisher' s exact test.
RESULTS: There was a significant correlation between histological grade and hemodynamic pattern (P < 0.05). There was a significant correlation between histological grade and signal intensity in the hepatobiliary phase (P < 0.05) in group A lesions. There was no significant correlation between histological grade and signal intensity in the hepatobiliary phase in group B or C lesions (P > 0.05).
CONCLUSION: Signal intensity in the hepatobiliary phase correlated with histological grade in the lesions that maintained portal blood flow, but did not correlate in lesions that showed decreased or defective portal blood flow.

Entities:  

Keywords:  Early hepatocellular carcinoma; Gadoxetic acid; Gd-EOB-DTPA; Hepatocellular carcinoma; Primovist

Mesh:

Substances:

Year:  2011        PMID: 21941417      PMCID: PMC3163248          DOI: 10.3748/wjg.v17.i30.3503

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma.

Authors:  Chao-Shiang Li; Ran-Chou Chen; Jiunn-Ming Lii; Wei-Tsung Chen; Li-Sun Shih; Ting-An Zhang; Hsing-Yang Tu
Journal:  J Comput Assist Tomogr       Date:  2006 Jul-Aug       Impact factor: 1.826

2.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

Authors:  T J Vogl; S Kümmel; R Hammerstingl; M Schellenbeck; G Schumacher; T Balzer; W Schwarz; P K Müller; W O Bechstein; M G Mack; O Söllner; R Felix
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

3.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

Authors:  O Matsui; M Kadoya; T Kameyama; J Yoshikawa; T Takashima; Y Nakanuma; M Unoura; K Kobayashi; R Izumi; M Ida
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

4.  Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.

Authors:  J P Earls; N D Theise; J C Weinreb; D R DeCorato; G A Krinsky; N M Rofsky; H Mizrachi; L W Teperman
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

5.  Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.

Authors:  Rieko Shinmura; Osamu Matsui; Satoshi Kobayashi; Noboru Terayama; Junichiro Sanada; Kazuhiko Ueda; Toshifumi Gabata; Masumi Kadoya; Shiro Miyayama
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

6.  Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Authors:  Kazuhiro Saito; Fumio Kotake; Naoki Ito; Taizo Ozuki; Ryuji Mikami; Kimihiko Abe; Yoko Shimazaki
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

Review 7.  Early hepatocellular carcinoma and dysplastic nodules.

Authors:  Masamichi Kojiro; Tania Roskams
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

Review 8.  Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors.

Authors:  M Kojiro; O Nakashima
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

9.  Early hepatocellular carcinoma as an entity with a high rate of surgical cure.

Authors:  T Takayama; M Makuuchi; S Hirohashi; M Sakamoto; J Yamamoto; K Shimada; T Kosuge; S Okada; K Takayasu; S Yamasaki
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

10.  Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views.

Authors:  F Kondo; Y Kondo; Y Nagato; M Tomizawa; K Wada
Journal:  J Gastroenterol Hepatol       Date:  1994 Nov-Dec       Impact factor: 4.029

View more
  5 in total

Review 1.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

Review 2.  Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Authors:  Alexander Kagen; Kathryn Fowler; Claude B Sirlin
Journal:  Hepat Oncol       Date:  2013-12-20

Review 3.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

4.  Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.

Authors:  Hee Yeon Kim; Jong Young Choi; Chung-Hwa Park; Myeong Jun Song; Do Seon Song; Chang Wook Kim; Si Hyun Bae; Seung Kew Yoon; Young Joon Lee; Sung Eun Rha
Journal:  J Gastroenterol       Date:  2013-01-11       Impact factor: 7.527

5.  Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Authors:  Jie Chen; Mingpeng Wu; Rongbo Liu; Siyi Li; Ronghui Gao; Bin Song
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.